Verification register Bio, Health & Neuro
Current reading
Readiness band and full integer triple
AI-assisted assembly · derived results
Readiness band
Unknown
Primary summary from verified readiness
- Confidence
- 61% · stale
- Computed at
- 2026-09-22T23:27:14.984527+00:00
- Claimed
- 25
- Reported
- 21
- Verified
- 14
- Gap
- +11
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed leads verified
Evidence strength Growing
Decision
What the current evidence supports
Human editorial judgment · 2026-09-22
Too early to adopt
- Why
- Dual-regulator IND clearance and reputable trial sites are credible milestones, but the asset is at first-patient-dosed with all efficacy evidence still in mice; primary sources are company press releases. No real-world clinical signal to evaluate yet.
- Next
- Re-check in 2026 for the Phase I monotherapy dose-escalation safety/tolerability readout and any anti-PD-1 combination data before forming a maturity view.
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 6
- Tier 1
- 0
- Tier 2
- 2
- Tier 3
- 4
- Supports
- 2
- Contradicts
- 2
- Context
- 2
- Latest observed
- 2025-11-21
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Revision 2
- 2026-07-19 Reading moved from unknown to unknown.
- 2026-09-22 Reading moved from unknown to unknown.